Anna Lawson is a Senior Director of Global Policy & Advocacy in Rare Disease, bringing extensive experience from previous roles in major pharmaceutical companies. They have served as a Senior Director for Rare Disease Policy & Advocacy at AstraZeneca from 2025 to 2022, following positions as Global Policy & Advocacy Director for Respiratory and Senior Policy & Advocacy Director for Respiratory and Immunology. Previously, they were the Director of Global Public Health at ViiV Healthcare and led EU Policy, Community, and Advocacy initiatives. Their early career includes roles at GlaxoSmithKline and Kings College Hospital focused on neurology and Parkinson’s disease.
This person is not in the org chart
This person is not in any teams
This person is not in any offices